These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
787 related articles for article (PubMed ID: 32294179)
1. Coronavirus Infections and Type 2 Diabetes-Shared Pathways with Therapeutic Implications. Drucker DJ Endocr Rev; 2020 Jun; 41(3):. PubMed ID: 32294179 [TBL] [Abstract][Full Text] [Related]
2. COVID-19: is there a link between the course of infection and pharmacological agents in diabetes? Filardi T; Morano S J Endocrinol Invest; 2020 Aug; 43(8):1053-1060. PubMed ID: 32495299 [TBL] [Abstract][Full Text] [Related]
3. COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity? Bassendine MF; Bridge SH; McCaughan GW; Gorrell MD J Diabetes; 2020 Sep; 12(9):649-658. PubMed ID: 32394639 [TBL] [Abstract][Full Text] [Related]
4. Sitagliptin Repositioning in SARS-CoV-2: Effects on ACE-2, CD-26, and Inflammatory Cytokine Storms in the Lung. Dastan F; Abedini A; Shahabi S; Kiani A; Saffaei A; Zare A Iran J Allergy Asthma Immunol; 2020 May; 19(S1):10-12. PubMed ID: 32534505 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin Converting Enzyme-2 (ACE2) Receptors, asthma and severe COVID-19 infection risk. Öztürk AB; Çağlayan B Eur Ann Allergy Clin Immunol; 2020 Nov; 52(6):282-285. PubMed ID: 32914945 [No Abstract] [Full Text] [Related]
7. Role of dipeptidyl peptidase-4 inhibitors in patients with diabetes infected with coronavirus-19. Chen CF; Chien CH; Yang YP; Chou SJ; Wang ML; Huo TI; Lin CC J Chin Med Assoc; 2020 Aug; 83(8):710-711. PubMed ID: 32349031 [TBL] [Abstract][Full Text] [Related]
8. Quantitative Proteomic Analysis of the Expression of SARS-CoV-2 Receptors in the Gut of Patients with Chronic Enterocolitis. Park J; Jeong D; Chung YW; Kim DH; Cheon JH; Ryu JH Yonsei Med J; 2020 Oct; 61(10):891-894. PubMed ID: 32975064 [TBL] [Abstract][Full Text] [Related]
9. The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2. Chen L; Li X; Chen M; Feng Y; Xiong C Cardiovasc Res; 2020 May; 116(6):1097-1100. PubMed ID: 32227090 [TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 Pathogenesis: Imbalance in the Renin-Angiotensin System Favors Lung Fibrosis. Delpino MV; Quarleri J Front Cell Infect Microbiol; 2020; 10():340. PubMed ID: 32596170 [No Abstract] [Full Text] [Related]
11. Use of pioglitazone in people with type 2 diabetes mellitus with coronavirus disease 2019 (COVID-19): Boon or bane? Jagat J M; Kalyan K G; Subir R Diabetes Metab Syndr; 2020; 14(5):829-831. PubMed ID: 32540737 [TBL] [Abstract][Full Text] [Related]
12. Single-cell analysis of SARS-CoV-2 receptor ACE2 and spike protein priming expression of proteases in the human heart. Liu H; Gai S; Wang X; Zeng J; Sun C; Zhao Y; Zheng Z Cardiovasc Res; 2020 Aug; 116(10):1733-1741. PubMed ID: 32638018 [TBL] [Abstract][Full Text] [Related]
13. Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19. Solerte SB; Di Sabatino A; Galli M; Fiorina P Acta Diabetol; 2020 Jul; 57(7):779-783. PubMed ID: 32506195 [TBL] [Abstract][Full Text] [Related]
14. Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights. Stoian AP; Papanas N; Prazny M; Rizvi AA; Rizzo M J Cardiovasc Pharmacol Ther; 2020 Nov; 25(6):494-496. PubMed ID: 32618198 [TBL] [Abstract][Full Text] [Related]
15. Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits. Rao S; Lau A; So HC Diabetes Care; 2020 Jul; 43(7):1416-1426. PubMed ID: 32430459 [TBL] [Abstract][Full Text] [Related]
16. COVID-19 and diabetes: Can DPP4 inhibition play a role? Iacobellis G Diabetes Res Clin Pract; 2020 Apr; 162():108125. PubMed ID: 32224164 [No Abstract] [Full Text] [Related]
17. Clinical analysis of sinus bradycardia in patients with severe COVID-19 pneumonia. Hu L; Gong L; Jiang Z; Wang Q; Zou Y; Zhu L Crit Care; 2020 May; 24(1):257. PubMed ID: 32456695 [No Abstract] [Full Text] [Related]
18. Combating sars-cov-2 through lipoxins, proteasome, caveolin and nuclear factor-κb pathways in non-pregnant and pregnant populations. Celik O; Celik N; Aydin S; Baysal B; Aydin S; Saglam A; Gursu Y; Dalkilic S; Ulas M; Ozcil MD; Tayyar AT; Cengiz F; Ugur K; Akkoc RF; Ersahin AA Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):221-229. PubMed ID: 32538775 [TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients. Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814 [TBL] [Abstract][Full Text] [Related]
20. Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells. Stelzig KE; Canepa-Escaro F; Schiliro M; Berdnikovs S; Prakash YS; Chiarella SE Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1280-L1281. PubMed ID: 32432918 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]